GLAXO OPERATIONS UK LIMITED

Company Information

Company Number
00711851
Registered Address
980 Great West Road, Brentford, Middlesex, TW8 9GS
Status
Active
Employee Count
3156.0
Turnover
638240000.0
EBITDA
126115000.0

Additional Details

Company Type
Private limited Company
Incorporated On
1 January 1962
Nature of Business
21200 - Manufacture of pharmaceutical preparations
Industries
0
Region
London

Company Location

Loading map...

Financial Metrics

Cash
£0.00
Net Worth
£944,251,000.00
Total Current Assets
£185,408,000.00
Total Current Liabilities
£417,959,000.00
Reporting Period
2023-07-01 to 2023-12-31Filed: 2024-01-30

Time to Pay

Average Time to Pay
67 days
Shortest Period:0 days
Longest Period:60 days
Max Contractual:60 days

Payment Timeline

Within 30 Days
15%
31-60 Days
19%
After 60 Days
66%
Not Paid Within Terms5%

Payment Features

Participates in Codes✗ No
E-Invoicing✓ Yes
Supply Chain Finance✓ Yes

Payment Time Trends

Payment Distribution Trends

Performance Reports History

Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Jul 2023 - 31 Dec 202330 Jan 20246715%19%66%5%
01 Jan 2023 - 30 Jun 202327 Jul 20236915%17%68%5%
01 Jul 2022 - 31 Dec 202227 Jan 20237310%14%76%8%
01 Jan 2022 - 30 Jun 202228 Jul 20227112%13%75%6%
01 Jul 2021 - 31 Dec 202128 Jan 20227112%23%65%7%
01 Jan 2021 - 30 Jun 202129 Jul 20217012%15%72%7%
01 Jul 2020 - 31 Dec 202028 Jan 20217020%17%63%7%
01 Jan 2020 - 30 Jun 202029 Jul 20207013%16%71%7%
01 Jul 2019 - 31 Dec 201929 Jan 20206715%22%63%7%
01 Jan 2019 - 30 Jun 201930 Jul 2019708%30%62%9%
01 Jul 2018 - 31 Dec 201831 Jan 2019756%27%67%14%
01 Jan 2018 - 30 Jun 201830 Jul 2018736%16%78%16%

Company Summary

GLAXO OPERATIONS UK LIMITED is a leading pharmaceutical company that operates in the United Kingdom

The company is committed to sustainability and has implemented various programs to reduce its environmental impact

They offer a wide range of products and services in the healthcare industry, including prescription medicines, vaccines, and consumer healthcare products

The company's sustainability program focuses on reducing their carbon footprint, conserving natural resources, and promoting sustainable practices throughout their operations

They have set ambitious targets to reduce their greenhouse gas emissions, waste generation, and water consumption

GLAXO OPERATIONS UK LIMITED also works closely with suppliers and partners to ensure sustainable sourcing of materials and ingredients

The key people at GLAXO OPERATIONS UK LIMITED include the CEO Emma Walmsley and the Chairman Sir Jonathan Symonds

They are supported by a team of experienced professionals who are dedicated to the company's mission of improving global health

The company's registered office address is at 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

GLAXO OPERATIONS UK LIMITED's website, www.gsk.com, provides information on their products, sustainability initiatives, and corporate responsibility efforts

Customers can also access resources on health and wellbeing, research and development, and career opportunities

The website also includes contact information for inquiries and customer support

In conclusion, GLAXO OPERATIONS UK LIMITED is a reputable pharmaceutical company in the UK that is committed to sustainability and providing high-quality products and services in the healthcare industry

With a strong leadership team and a focus on environmental responsibility, the company continues to make a positive impact on society

Company Review

Trend Analysis

The average time for GLAXO OPERATIONS UK LIMITED to pay invoices has fluctuated over the past three years, with a slight decrease in 2021 compared to the previous year. The percentage of invoices paid within 30 days has remained relatively consistent, while there has been a decrease in the percentage of invoices paid between 31 and 60 days. However, there has been an increase in the percentage of invoices paid later than 60 days.

Volatility Analysis

The average time to pay and the percentages of invoices paid within 30 days and between 31 and 60 days have had moderate volatility, while the percentage of invoices paid later than 60 days has had high volatility over the past three years.

Summary Analysis

From 2018 to 2020, GLAXO OPERATIONS UK LIMITED had an average time to pay of 72 days, with 6% of invoices paid within 30 days, 25% of invoices paid between 31 and 60 days, and 68% of invoices paid later than 60 days. However, in 2021, there was a decrease in the average time to pay to 70 days, with 12% of invoices paid within 30 days, 19% of invoices paid between 31 and 60 days, and 68% of invoices paid later than 60 days. In the first half of 2022, there was a slight increase in the average time to pay to 71 days, with 12% of invoices paid within 30 days, 13% of invoices paid between 31 and 60 days, and 75% of invoices paid later than 60 days.

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

Qualifying contracts for this entity contain a number of different payment periods:  Immediate  30 days  60 days  45 days  30 days and 5th of the following month  60 days and 5th of the following month Payments are made from date of receipt of invoice.

Were there any changes to the standard payment terms in the reporting period?

Yes – Standard 30-day terms for SMEs were introduced in place of a previous offer of 30 day terms upon application by the vendor.

Any other information about payment terms

1) Statistics Reported: Intercompany invoices and performance have been excluded from reported statistics as these are generally wholly owned group companies and would distort performance if included. 2) Payment terms for SMEs and 'Paid on Time' monitoring: Preferential payment terms of 30 days are put in place for vendors that are confirmed as SMEs (Small and Medium Enterprises). We closely monitor our KPIs on a weekly basis to ensure that vendors (including SMEs) are paid on time. Corrective actions are taken to remedy any late payment issues where these are within the entity’s control.

Maximum contractual payment period agreed

60

Dispute Resolution Process

We offer our suppliers the following support and service:  Enquiries and complaints can be logged through our Helpdesk support system (mail or telephone). Issues are often related to incorrect invoice submission, payment terms are not as per contract, PO details are wrong / nonexistent etc. Key performance metrics are monitored for quality of Helpdesk support.  Our Supplier web pages also include details and a link to our Speak Up channels that enable concerns to be raised, including channels managed independently of GSK and the option to do so anonymously, although naturally it helps in resolving matters if we know as much as possible about the issue and complainant.  We have invested in Customer Relationship Management (CRM) to ensure effective and independent supplier follow up and support to our suppliers raising issues.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available